Genetic and epileptic features in Rett syndrome

Area of Science:

• Neuroscience
• Genetics
• Pediatrics

Background:

• Rett syndrome is a severe neurodevelopmental disorder primarily affecting females.
• Mutations in the methyl-CpG-binding protein 2 (MECP2) gene are found in 80-90% of cases.
• Epilepsy is a common and significant comorbidity in Rett syndrome.

Purpose of the Study:

• To conduct a comprehensive analysis of genetic and clinical features in Rett syndrome patients.
• To specifically investigate the relationship between MECP2 mutations and epileptic features.
• To assess the impact of epilepsy on motor function and cognitive development.

Main Methods:

• Retrospective review of 20 patients diagnosed with MECP2 mutations.
• Inclusion criteria: clinical diagnosis of Rett syndrome.
• Evaluations included clinical features, epilepsy classification, EEG analysis, and seizure treatment.

Main Results:

• Fourteen different MECP2 mutations were identified, including one novel mutation.
• Epilepsy was present in 70% of patients, with onset around 3 years of age.
• Patients with epilepsy showed more significant delays in motor function and lower developmental scores compared to those without epilepsy.

Conclusions:

• Epilepsy is a frequent feature in Rett syndrome patients with MECP2 mutations.
• A tendency towards more severe motor impairment and cognitive deterioration exists in Rett syndrome patients with epilepsy.
• No clear genotype-phenotype correlation was found regarding epilepsy.